In the midst of the coronavirus disease 2019 (COVID-19) pandemic, we are seeing widespread
disease burden affecting patients of all ages across the globe. However, much remains …

Background: Distribution of mRNA-based SARS-CoV-2 vaccines to healthcare personnel (HCP)
in the United States began in December 2020, with efficacy≥ 90%. However, …

OBJECTIVES Pediatric hospitalization rates are used as a marker of coronavirus disease
2019 (COVID-19) disease severity in children but may be inflated by the detection of mild or …

We developed an assay that detects minus-strand RNA as a surrogate for actively replicating
severe acute respiratory syndrome coronavirus 2. We detected minus-strand RNA in 41 …

Importance Central catheter–associated bloodstream infections (CLABSIs) and catheter-associated
urinary tract infections (CAUTIs) increase morbidity, mortality, and health care costs …

Background Although mRNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccines report >90% efficacy, breakthrough infections occur. Little is known about …

Although much is known about complicated pneumonia, it remains a significant burden. New
diagnostic and therapeutic interventions hold much promise. This review seeks to provide …

In this retrospective report, 189 of 660 SARS-CoV-2 cases detected in healthcare personnel
at an academic medical center occurred post-vaccination. Incidence of the L452R mutation …

Objective: We assessed the magnitude of unidentified coronavirus disease 2019 (COVID-19)
in our healthcare personnel (HCP) early in the COVID-19 pandemic, and we evaluated risk …

Methods: We conducted this CLABSI reduction improvement initiative at a 395-bed
freestanding, academic, university-affiliated children’s hospital. A mesosystem-focused A3 …